Dok-2 Polyclonal Antibody

The protein encoded by DOK2 (docking protein 2)is constitutively tyrosine phosphorylated in hematopoietic progenitors isolated from chronic myelogenous leukemia (CML) patients in the chronic phase. It may be a critical substrate for p210 (bcr/abl), a chimeric protein whose presence is associated with CML. This encoded protein binds p120 (RasGAP) from CML cells.

The Dok-2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Dok-2 protein expression in various biological samples. This antibody is produced through a rigorous process, ensuring its high affinity and specificity towards Dok-2.

The Dok-2 Polyclonal Antibody exhibits exceptional sensitivity, enabling the detection of even low levels of Dok-2 protein expression. It has been extensively validated for use in various applications, including Western blotting, immunohistochemistry, and immunofluorescence.

This antibody is manufactured using state-of-the-art techniques and undergoes stringent quality control measures to ensure batch-to-batch consistency and optimal performance. It is supplied as a liquid formulation, allowing for easy and convenient handling.

The Dok-2 Polyclonal Antibody is suitable for use in both research and clinical settings, providing valuable insights into the role of Dok-2 in cellular signaling pathways and disease progression. Its versatility and reliability make it an indispensable tool for scientists and clinicians alike.

Order the Dok-2 Polyclonal Antibody today and unlock the potential of your research by gaining a deeper understanding of Dok-2 protein expression and its implications in various biological processes.